Profiling persistent tubercule bacilli from patient sputa during therapy predicts early drug efficacy

  • Isobella Honeyborne, Timothy D. McHugh, Iitu Kuittinen, Anna Cichonska, Dimitrios Evangelopoulos, Katharina Ronacher, Paul D. van Helden, Stephen H. Gillespie, Delmiro Fernandez-Reyes, Gerhard Walzl, Juho Rousu, Philip D. Butcher, Simon J. Waddell
  • BMC Medicine, April 2016, Springer Science + Business Media
  • DOI: 10.1186/s12916-016-0609-3

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1186/s12916-016-0609-3